JRCT ID: jRCT1040210116
Registered date:25/12/2021
Retrospective multicenter clinical study of risk factors for cetuximab-related infusion reaction in Japanese patients
Basic Information
Recruitment status | Not Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Colorectal Cancer, Head and Neck Cancer |
Date of first enrollment | 31/01/2022 |
Target sample size | 244 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | The exploratory factor analysis of the risk of cetuximab-related infusion reaction |
---|---|
Secondary Outcome | the rate of cetuximab-related infusion reaction the percentage of infusion reaction onsets according to adverse event-grades the percentage of medical interventions according to adverse event-grades |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Over 20 years old,Japanese, the first administration of cetuximab with chemotherapy or alone |
Exclude criteria | The patients who have allergic reaction during chemotherapy administration on the same day |
Related Information
Primary Sponsor | Onoda Chiharu |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | The Mt.Fuji Foundation for Healthcare Innovation and Cluster Development |
Secondary ID(s) |
Contact
Public contact | |
Name | Chiharu Onoda |
Address | 1000 Dohara,Yaizu,Shizuoka Shizuoka Japan 425-8505 |
Telephone | +81-54-623-3111 |
chiharu.onoda@hospital.yaizu.shizuoka.jp | |
Affiliation | Yaizu City Hospital |
Scientific contact | |
Name | Chiharu Onoda |
Address | 1000 Dohara,Yaizu,Shizuoka Shizuoka Japan 425-8505 |
Telephone | +81-54-623-3111 |
chiharu.onoda@hospital.yaizu.shizuoka.jp | |
Affiliation | Yaizu City Hospital |